/PRNewswire/ - Thryv Therapeutics Inc. is pleased to announce the appointment of Dr. Debra Odink to President and Chief Development Officer of the company and.
Milestone Pharmaceuticals Inc. (NASDAQ:MIST – Get Rating) Director Paul F. Truex acquired 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 31st. The shares were acquired at an average cost of $5.60 per share, with a total value of $28,000.00. Following the transaction, the director now directly owns 81,780 shares […]
CymaBay Appoints Thomas Wiggans and Janet Dorling to Board of Directors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.